A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product

Pfizer

Status: Completed

Conditions: Siderosis

Treatments: Other: Observational Trial

Study type: Observational

Funder types: Industry

Identifiers

NCT00471224

A4321004

Details and patient eligibility

About

This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).

Enrollment: 16 patients

Sex: All

Ages: 55 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A subset of subjects enrolled in study A4321001 and who have received formulated drug product (Lot 8716-098) will be included in the safety follow up study.

Exclusion criteria

None

Trial design

16 participants in 1 patient group

Patients who have received drug.

Description:

Patients who have received drug.

Treatment:

Other: Observational Trial